Navigation Links
New drug prevents spread of human prostate cancer cells
Date:4/3/2012

CHICAGO --- A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the cancer cells and immobilizes them.

Prostate cancer is the second-leading cause of cancer death in North American males. Death is mainly caused by metastasis, prostate cancer cells moving out of prostate tissue and spreading to other organs.

"This is an extremely promising new therapeutic that locks down aggressive prostate cancer cells so they don't move," said Raymond Bergan, M.D., director of experimental therapeutics for the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "The spread of prostate cancer is what kills men. Cancer cells have a switch that tells them to keep moving all the time. This drug turns it off."

The drug works by binding to and disabling proteins in the cancer cell that instruct it to move, said Bergan, a professor of medicine at Northwestern's Feinberg School of Medicine and a physician at Northwestern Memorial Hospital.

The research was presented April 3 at the American Association for Cancer Research Annual Meeting 2012 in Chicago by Li Xu, a research assistant professor of medicine at the Feinberg School. She helped develop the drug, along with Karl Scheidt, an associate professor of chemistry at the Weinberg College of Arts and Sciences.

In the study, Northwestern researchers transplanted aggressive human prostate cancer cells into mice prostate tissue and fed the mice with the new drug for five weeks. The drug inhibited movement of the cells and prevented them from metastasizing to the lung, one of the tissues to which prostate cancer spreads in men.

Xu said she conducted extensive toxicity studies, including on normal human cells, and found that the drug, called KBU2046, is nontoxic and does not cause any harmful effects.

"We envision that this drug, if shown to be effective in clinical trials, could be used to treat men diagnosed with prostate cancer, so they wouldn't need more aggressive procedures," Bergan said. "Or, the drug could augment the effectiveness of surgery and radiation."

Bergan hopes to test the drug in a clinical trial.


'/>"/>
Contact: Marla Paul
Marla-Paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Related medicine news :

1. Colonoscopy prevents deaths from colon cancer
2. Dirt prevents allergy
3. Drug prevents bone loss side effects of breast cancer medication
4. Knockout of protein prevents colon tumor formation in mice
5. Marijuana administration after a traumatic experience prevents post-traumatic stress symptoms
6. Adding a stent during minimally invasive surgery to repair aneurysms prevents recurrence
7. Tai Chi Prevents Falls, Boosts Mental Health in Seniors: Study
8. UNC-led study shows early treatment with antiretroviral therapy prevents HIV transmission
9. Tobacco-derived compound prevents memory loss in Alzheimers disease mice
10. Early infusion of donor T cells prevents graft versus host disease in blood cancer patients
11. Tomatoes found to contain nutrient which prevents vascular diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The Georgia State University College of Law ... Atlanta Urban Design Commission. , The annual award recognizes projects, programs, individuals and organizations ... the preservation of its physical heritage and the balance between the old and the ...
(Date:5/25/2016)... The Netherlands (PRWEB) , ... May 25, 2016 , ... ... unprecedented freedom of movement to motion capture, all by utilizing a common Wi-Fi network ... allows users to transmit data from any location with Wi-Fi, and use a mobile ...
(Date:5/25/2016)... ... , ... One Florida-based plastic surgeon’s enthusiasm is proving to be contagious among ... May 13th on Vanity Fair. In fact, as the article explains, more than a ... more than 800,000 Snapchat fans. Commenting on this trend, Dr. Michael Salzhauer, also known ...
(Date:5/25/2016)... ... 2016 , ... The Bank of America Charitable Foundation has awarded a grant ... a pathway to employment and successful careers in healthcare. On Wednesday, May 4th, Rick ... and CEO of Medisend, parent organization and home of the General Myers Veterans Program. ...
(Date:5/25/2016)... ... May 25, 2016 , ... New studies published today by ... across 15 states. The outcomes examined in these studies include recovery of physical ... satisfaction with medical care. , “The goal of the studies is to provide ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... Cirujanos holandeses han puesto en marcha una ... compartir sus mejores prácticas por el mundo y tratar ... Europa, África, Asia y Estados ... combina la transmisión en vivo con mensajería instantánea y ... "Imagine un médico de Medicines sans Frontieres ...
Breaking Medicine Technology: